• Essex Bio-Technology repurchased 18,000 ordinary shares on Aug. 21, 2026 for treasury.
• Buyback price was HKD 2.3 per share; total consideration was HKD 41,400.
• Issued shares excluding treasury fell to 565,162,000; treasury shares rose to 1,844,000.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Essex Bio-Technology Limited published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260821-12294161), on August 21, 2026, and is solely responsible for the information contained therein.